Effects of Curcumin and Its Analogue Desmethoxycurcumin on miR-133b and Its Target Gene GSTP-1 in Cisplatin-resistant Ovarian Cancer Cells
This study demonstrated the potential of CUR and DMC to enhance the efficacy of cisplatin in ovarian cancer treatment. The observed decrease in GSTP-1 and miR-133b expression in cisplatin-resistant cells suggests their involvement in drug resistance and highlights their potential as therapeutic targets.
Authors
- Esin Aktaş Çetin (ORCID: https://orcid.org/0000-0002-8078-2780)
- Özlem Timirci‐Kahraman (ORCID: https://orcid.org/0000-0002-2641-5613)
- Deryanaz Billur (ORCID: https://orcid.org/0000-0002-6079-8224)
- Turgay İşbir (ORCID: https://orcid.org/0000-0002-7350-6032)
- Esin Bayralı Ülker
- Mehmet Fatih Seyhan (ORCID: https://orcid.org/0000-0002-6218-0049)
Institutions
- Yeditepe University (TR)
- Istanbul Yeni Yüzyıl University (TR)
- Istanbul University (TR)
Publication Details
- Journal
- Anticancer Research
- Published
- 2024-12-01
- DOI
- https://doi.org/10.21873/anticanres.17362
- Citations
- 4
- Primary Topic
- Curcumin's Biomedical Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.68